Abstract
Less is known about the impact of heart failure (HF) and coronary artery disease (CAD) on motor recovery after cerebral infarction although previous studies have reported that preexisting HF and CAD were associated with increased mortality in stroke patients as well as unfavorable functional outcomes. In this study, we aimed to accurately evaluate the impact of HF and CAD on motor recovery after cerebral infarction by including only patients with corona radiata using diffusion tensor tractography. A total of 110 patients were recruited, and diffusion tensor tractography was performed within 7 to 30 days of infarct onset. Motor function on the affected side was evaluated for each patient using the upper myocardial infarction (MI), lower MI, modified Brunnstrom classification, and the functional ambulation category at the onset of stroke and 6 months after the onset of stroke. The influence of preexisting HF and CAD on the recovery of motor function were analyzed, adjusting for critical factors for motor recovery after stroke, namely the corticospinal tract condition, lesion location, age, and upper and lower MIs at the onset of stroke. No significant difference was found in motor outcomes according to the presence of HF, while poorer outcomes in motor function of the lower extremities and gait ability were observed in patients with CAD compared to patients without CAD. Motor function of the lower extremities and gait ability in cerebral infarct patients with CAD is more impaired than those without CAD.
Keywords: coronary artery disease, corticospinal tract, heart failure, motor recovery, recovery of function
1. Introduction
Motor dysfunction is a major sequela of cerebral infarctions. More than half of the patients have significant motor dysfunction after cerebral infarction. This hinders stroke patients’ independent activities of daily living and deteriorates their quality of life. Several factors, including lesion location, condition of the corticospinal tract (CST), age, and initial motor function after cerebral infarction, affect motor outcomes after cerebral infarction.[1–4]
Heart failure (HF) is a complex clinical syndrome rather than a single pathological diagnosis, arising from structural and/or functional impairment of the heart which can lead to elevated intracardiac pressure and reduced cardiac output.[5] HF is known to be a risk factor for cerebral infarction.[6,7] In addition, previous studies have identified that preexisting HF is associated with increased mortality in stroke patients as well as unfavorable functional outcomes at discharge.[8–10] Similarly, coronary artery disease (CAD) is independently associated with increased mortality in patients with stroke,[11] and is the most common etiology of HF.[12] However, most studies have evaluated the functional status of patients using only modified Ranking Scale score, a seven-point scale ranging from 0 (no symptoms) to 6 (death), rather than directly evaluating motor function, and did not control for factors that can affect motor recovery after stroke other than age and stroke severity represented by National Institutes of Health Stroke Scale scores. Therefore, it remains elusive whether the presence of HF has an impact on motor recovery itself after stroke.
In this study, we aimed to accurately evaluate the impact of HF and CAD on motor recovery after cerebral infarction by including only patients with corona radiata infarct with severe motor impairment at the onset of stroke and controlling for CST condition using diffusion tensor tractography, age, and preexisting motor function.
2. Materials and methods
2.1. Subjects
The study protocol was approved by the institutional research board of the university hospital. Written informed consent was waived by the institutional review board of a university hospital because this study was performed retrospectively using anonymous data. The Helsinki Declaration was adhered to in this study. A total of 110 patients (age: 64.8 ± 9.5, male:female = 52:58) admitted to the university hospital between January 2006 and October 2019 were enrolled in this retrospective study (Table 1). Inclusion criteria were as follows: (1) first ever stroke; (2) age 20 to 79 years; (3) severe weakness of the affected extremities, to the extent of inability to move the affected limbs without gravity and complete weakness of the affected hand (finger flexors and extensors) within 24 hours of onset; (4) an infarct at the level of the corona radiata explaining motor weakness (including at least the posterior half of the middle third of the corona radiata and fibers adjacent to the lateral wall of the inferior horn of the lateral ventricle) determined by brain MRI with confirmation by a neuroradiologist; (5) diffusion tensor tractography performed within 7 to 30 days of onset for the evaluation of preservation of CST. Patients who had serious medical complications such as pneumonia or sepsis, which would hinder rehabilitation from onset to final evaluation, were excluded. All patients received movement therapy for 6 days/week (Monday through Friday, 2.5 h/day; Saturday, 1 h/day) to improve motor function, postural control, and movement patterns in the affected extremity.
Table 1.
Changes in motor function according to the presence of preexisting heart failure (HF).
| Variables | Patients with HF (n = 13) | Patients without HF (n = 97) | P-value* |
|---|---|---|---|
| Upper limb MI | |||
| At infarct onset | 5.5 ± 8.6 | 8.3 ± 9.0 | 0.271 |
| At 6 months after infarct onset | 53.3 ± 22.9 | 62.4 ± 22.1 | 0.542 |
| Lower limb MI | |||
| At infarct onset | 12.5 ± 14.0 | 13.6 ± 12.5 | 0.849 |
| At 6 months after infarct onset | 59.5 ± 22.0 | 65.5 ± 20.0 | 0.249 |
| MBC | |||
| At infarct onset | 1.0 ± 0.0 | 1.0 ± 0.0 | 1.000 |
| At 6 months after infarct onset | 3.6 ± 1.9 | 4.0 ± 1.9 | 0.982 |
| FAC | |||
| At infarct onset | 0.0 ± 0.0 | 0.0 ± 0.0 | 1.000 |
| At 6 months after infarct onset | 2.9 ± 1.1 | 3.3 ± 1.3 | 0.909 |
FAC = functional ambulation category, HF = heart failure, MBC = the modified Brunnstrom classification, MI = myocardial infarction.
P values determined using ANCOVA and represent differences in motor function at 6 months after infarct onset between the patients with HF and those without HF.
2.2. Determining the presence of chronic heart failure and coronary artery disease
All patients underwent evaluation of risk factors for stroke, including history of hypertension, diabetes mellitus, dyslipidemia, cigarette smoking, heart disease including atrial fibrillation, and CAD, and underwent repeated electrocardiogram and echocardiography. Atrial fibrillation was defined according to the criteria suggested by the European Society of Cardiology and was confirmed by repeated electrocardiogram; CAD, including myocardial infarction (MI), angina pectoris (AP), angioplasty, or coronary artery bypass surgery, was assessed by thorough history taking and medical confirmation. HF was defined according to the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[5] and was confirmed by a cardiologist. HF severity was assessed using the New York Heart Association criteria. Among the 110 patients, 13 (11.8%) patients had HF, 4 (3.6%) patients had CAD (2 patients with previous MI and 2 patients with AP), and 1 patient had both HF and AP. The etiology and functional status of the patients with HF are summarized in Table 2.
Table 2.
Etiology of heart failure, NYHA functional status of patients with heart failure.
| Number (%) | |
|---|---|
| Etiology of heart failure | |
| Hypertension | 11 (84.6%) |
| Atrial fibrillation | 1 (7.7%) |
| Coronary artery disease | 1 (7.7%) |
| Heart failure functional class | |
| NYHA 1 | 10 (76.9%) |
| NYHA 2 | 3 (23.1%) |
| NYHA 3 | 0 |
| NYHA 4 | 0 |
| Left ventricular ejection fraction | |
| ≥50% (HFpEF) | 10 (76.9%) |
| 41–49% (HFmrEF) | 2 (15.4%) |
| <40% (HFrEF) | 1 (7.7%) |
HF = heart failure, HFmrEF = heart failure with mildly reduced ejection fraction, HFpEF = heart failure with preserved ejection fraction, HFrEF = heart failure with reduced ejection fraction, NYHA = New York Heart Association.
2.3. Diffusion tensor tractography
The mean duration from onset to diffusion tensor imaging (DTI) was 11.6 ± 5.9 days (range: 7–30 days). DTI was performed using a sensitivity-encoding head coil on a 1.5 T Philips Gyroscan Intera (Hoffman-LaRoche, Ltd, Best, the Netherlands) with single-shot echo-planar imaging and navigator echo. Sixty contiguous slices (matrix = 128 × 128; field of view = 221 × 221 mm2; time to echo = 76 ms; repetition time = 10,726 ms; sensitivity encoding factor = 2; echo planar imaging factor = 67; b = 1000 s/mm/mm; number of excitations = 1; and slice thickness = 2.3 mm) were acquired for each of the 32 noncollinear diffusion-sensitizing gradients. The scanning time for DTI acquisition was 7 minutes and 32 seconds. Head motion effects and image distortions due to eddy currents were corrected using affine multiscale two-dimensional (2D) registration. The integrity of the CST was evaluated via fiber assignment by continuous tracking using a three-dimensional fiber reconstruction algorithm in Philips PRIDE software (Philips Medical Systems, Best, the Netherlands). CST fiber tracking was performed with a fractional anisotropy (FA) threshold of 0.2 and a direction threshold of 60°. In each case, a seed region of interest (ROI) was drawn in the CST portion of the anterior mid-pons on a 2D FA color map, and another ROI was drawn in the CST portion of the anterior low pons on a 2D FA color map. Fiber tracts passing through both ROIs were designated as final tracts of interest (Fig. 1). In the 58 included patients, the CST was preserved around the infarct; in 52 patients, the CST was interrupted by the infarct.
Figure 1.
The corticospinal tracts depicted using diffusion tensor tractography. The left corticospinal tract was preserved around the infarct (left). The left corticospinal tract was interrupted by the infract.
2.4. Measurement of motor function
Motor function was measured twice in each patient: at infarct onset and 6 months after infarct onset. Motricity indices (MIs) were used to measure motor function (maximum score = 100). The function of the affected hand was categorized using the modified Brunnstrom classification (MBC) as follows: (1) unable to move fingers voluntarily; (2) able to move fingers voluntarily; (3) able to close the affected hand voluntarily but unable to open the hand; (4) able to grasp a card between the thumb and the medial side of the index finger and able to extend fingers slightly; (5) able to pick up and hold a glass and extend fingers; and (6) able to catch and throw a ball in a near-normal fashion and able to button and unbutton a shirt. Walking ability was quantified using the standardized functional ambulation category (FAC), which is based on the characterization of the level of assistance required during a 15-minute walk. The 6 FAC categories are as follows: (0) nonambulatory; (1) need for continuous support from 1 person; (2) need for intermittent support from 1 person; (3) need for verbal supervision only; (4) need for help on stairs and uneven surfaces; and (5) ability to walk independently anywhere. The reliability and validity of the MI, MBC, and FAC have been well established. We set MBC ≥ 5 and FAC ≥ 3 as the cutoff values for voluntary hand movement and gait achievement, respectively.
2.5. Statistical analysis
All statistical analyses were performed using SPSS version 23.0. Differences in the improvement of motor outcomes (upper limb MI, lower limb MI, MBC, and FAC) between patients with HF and those without HF and those between patients with CAD and patients without CAD were analyzed using one-way analysis of covariance (ANCOVA) with the preservation of CST, age, and upper limb and lower limb MIs at infarct onset as covariates. Statistical significance was set at P < .05.
3. Results
In the comparison between patients with HF and those without HF, no significant difference was observed in the measurements of motor function (upper MI, lower MI, MBC, and FAC) at 6 months after infarct onset (ANCOVA, P > .05) (Table 1). In contrast, in the comparison between patients with CAD and those without CAD, lower MI and FAC were significantly larger in patients without CAD than in those with CAD (ANCOVA, lower MI, P = .049; FAC, P < .001) (Table 3). However, upper MI and MBC at 6 months after infarct onset were not significantly different between patients with and without CAD (ANCOVA, P > .05) (Table 3).
Table 3.
Changes in motor function according to the presence of preexisting coronary artery disease (CAD).
| Variables | Patients with CAD (n = 4) | Patients without CAD (n = 106) | P-value* |
|---|---|---|---|
| Upper limb MI | |||
| At infarct onset | 11.3 ± 8.6 | 7.9 ± 9.0 | .444 |
| At 6 months after infarct onset | 63.8 ± 17.5 | 61.3 ± 22.5 | .508 |
| Lower limb MI | |||
| At infarct onset | 13.5 ± 11.6 | 13.5 ± 12.7 | 1.000 |
| At 6 months after infarct onset | 64.5 ± 13.9 | 64.8 ± 20.0 | .049 |
| MBC | |||
| At infarct onset | 1.0 ± 0.0 | 1.0 ± 0.0 | 1.000 |
| At 6 months after infarct onset | 5.0 ± 2.0 | 3.9 ± 1.9 | .977 |
| FAC | |||
| At infarct onset | 0.0 ± 0.0 | 0.0 ± 0.0 | 1.000 |
| At 6 months after infarct onset | 2.8 ± 1.0 | 3.3 ± 1.7 | <.001 |
Bolds indicate < .05.
FAC = functional ambulation category, HF = heart failure, MBC = the modified Brunnstrom classification, MI = myocardial infarction.
P values determined using ANCOVA and represent differences in motor function at 6 months after infarct onset between the patients with CAD and those without CAD.
4. Discussion
In this study, we investigated whether HF and CAD affect motor outcomes in patients with corona radiata infarct and found that there was no significant difference in motor outcomes according to the presence of HF, while poorer outcomes in motor function of the lower extremities and gait ability were observed in patients with CAD compared to patients without CAD.
HF is known to be associated with poor stroke outcomes, including higher short-term and long-term mortality rates, longer duration of hospital stay, more severe stroke symptoms, and higher numbers of patients discharged to long-term care facilities.[8–10] This can be explained by the physiological alterations seen in chronic HF, such as body fluid imbalances, worsening of cerebral tissue oxygenation, hemodynamic disturbances in arterial and venous systems, endothelial dysfunction, and proinflammatory and prothrombotic conditions.[7,13–15] However, although our study showed a tendency for poorer outcomes in patients with HF compared to those without HF, the differences did not reach statistical significance. The relatively small number of patients enrolled in this study might be responsible for this, aside from the fact that the prevalence of patients with HF in our study (11.8%) was similar to that in a previous study (9.1% in Pongmoragot et al, 2016 and 9.7% of Vemmos et al, 2012). In addition, the relatively mild symptoms of patients with HF in our study (the majority of patients with HF [76.9%] were categorized as New York Heart Association class 1 and had preserved ejection fraction) could be another explanation.
CAD shares a common mechanism of atherosclerosis with cerebral infarction, which is a systemic inflammatory vascular disorder.[16,17] preexisting CAD is associated with poor outcomes in stroke rehabilitation as well as an increased risk of short-term and long-term mortality.[11,18] Our findings are in accordance with those of previous studies in that patients with CAD showed poorer motor outcomes in the lower extremities and gait ability 6 months after the onset of stroke when compared to patients without CAD. Notably, these poorer outcomes in motor recovery were only observed in the lower extremities. Functional improvement of the lower extremities during rehabilitation is reported to be faster than that of the upper extremities in stroke patients.[19] In addition, the metabolic abnormalities of the lower extremities in patients with HF were reported to be more closely associated with systemic exercise intolerance when compared to those of the upper extremities.[20] In patients with sarcopenia, it is known that muscle strength of the lower extremities showed the strongest association with functional performance[21] and the longitudinal changes in the muscle mass of the lower extremities were significantly higher than those of the upper extremities.[22] Although no study has ever examined whether there is a discrepancy in the recovery of motor function between the upper and lower extremities in stroke patients with CAD, it could be hypothesized based on previous studies that (1) preexisting CAD might hinder the recovery of motor function in the lower extremities that precedes the recovery of motor function in the upper extremities and/or (2) the systemic effects of preexisting CAD would have a greater effect on the lower extremities than the upper extremities, as in the cases of patients with HF and sarcopenia.
To the best of our knowledge, this is the first study to directly evaluate the influence of preexisting HF and CAD on the recovery of motor function, adjusting for critical factors for motor recovery after stroke, namely CST condition, lesion location, age, and upper and lower MIs at the onset of stroke. However, our study has some limitations. Frist, the small number of patients with HF and CAD in our study is a major limitation. Second, the retrospective design hindered further interpretation of the study results. Third, we did not calculate an appropriate sample size for our study. The lack of predefined sample size may have impacted the statistical power and generalizability of our findings. Lastly, the wide age range of participants might have introduced confounding factors in the analysis of motor recovery results. Further well-designed prospective studies with larger scales are necessary to better understand this issue. Also, future studies should employ appropriate statistical methods to determine the optimal sample size and increase the robustness of the study. In addition, we recommend narrowing the age range or conducting subgroup analyses to better understanding how age impacts the observed effects.
Author contributions
Conceptualization: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Data curation: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Formal analysis: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Investigation: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Methodology: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Resources: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Software: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Supervision: Min Cheol Chang.
Validation: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Visualization: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Writing – original draft: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang.
Writing – review & editing: Soyoung Kwak, Sang Gyu Kwak, Min Cheol Chang
Abbreviations:
- 2D
- two-dimensional
- ANCOVA
- analyzed using one-way analysis of covariance
- AP
- angina pectoris
- CAD
- coronary artery disease
- CST
- corticospinal tract
- DTI
- diffusion tensor imaging
- FA
- fractional anisotropy
- FAC
- functional ambulation category
- HF
- heart failure
- MBC
- modified Brunnstrom classification
- MI
- myocardial infarction
- ROI
- region of interest
Our study protocol was approved by the institutional review board of Yeungnam university hospital. Written informed content to publish this report was waived by the institutional review board of Yeungnam university hospital due to the retrospective nature of this study. All methods were carried out in accordance with relevant guidelines and regulations.
The authors have no conflicts of interest to disclose.
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 00219725).
The datasets generated during and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.
How to cite this article: Kwak S, Kwak SG, Chang MC. The effect of preexisting heart failure and coronary artery disease on motor function recovery in cerebral infarct patients: A retrospective observational study. Medicine 2023;102:41(e35453).
Contributor Information
Soyoung Kwak, Email: sanggyu39@naver.com.
Sang Gyu Kwak, Email: sanggyu39@naver.com.
References
- [1].Bagg S, Pombo AP, Hopman W. Effect of age on functional outcomes after stroke rehabilitation. Stroke. 2002;33:179–85. [DOI] [PubMed] [Google Scholar]
- [2].Hendricks HT, van Limbeek J, Geurts AC, et al. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil. 2002;83:1629–37. [DOI] [PubMed] [Google Scholar]
- [3].Stinear C. Prediction of recovery of motor function after stroke. Lancet Neurol. 2010;9:1228–32. [DOI] [PubMed] [Google Scholar]
- [4].Kwak SY, Son SM, Choi BY, et al. Prognostic factors for motor outcome in patients with compressed corticospinal tract by intracerebral hematoma. NeuroRehabilitation 2011;29:85–90. [DOI] [PubMed] [Google Scholar]
- [5].McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726. [DOI] [PubMed] [Google Scholar]
- [6].Alosco ML, Brickman AM, Spitznagel MB, et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail. 2013;19:E29–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Kim W, Kim EJ. Heart failure as a risk factor for stroke. J Stroke. 2018;20:33–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Vemmos K, Ntaios G, Savvari P, et al. Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. Eur J Heart Fail. 2012;14:211–8. [DOI] [PubMed] [Google Scholar]
- [9].Pongmoragot J, Lee DS, Park TH, et al. Stroke and heart failure: clinical features, access to care, and outcomes. J Stroke Cerebrovasc Dis. 2016;25:1048–56. [DOI] [PubMed] [Google Scholar]
- [10].Siedler G, Sommer K, Macha K, et al. Heart failure in ischemic stroke: relevance for acute care and outcome. Stroke. 2019;50:3051–6. [DOI] [PubMed] [Google Scholar]
- [11].Wu CI, Wu CL, Su FC, et al. Association between pre-existing coronary artery disease and 5-year mortality in stroke patients with high-grade carotid artery stenosis. Eur Neurol. 2021;84:31–7. [DOI] [PubMed] [Google Scholar]
- [12].Lala A, Desai AS. The role of coronary artery disease in heart failure. Heart Fail Clin. 2014;10:353–65. [DOI] [PubMed] [Google Scholar]
- [13].Kim MS, Kim JJ. Heart and brain interconnection - clinical implications of changes in brain function during heart failure. Circ J. 2015;79:942–7. [DOI] [PubMed] [Google Scholar]
- [14].Kim JH, Shah P, Tantry US, et al. Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications. Curr Heart Fail Rep. 2016;13:319–28. [DOI] [PubMed] [Google Scholar]
- [15].Ferreira JP, Girerd N, Gregson J, et al. High-risk myocardial infarction database initiative. stroke risk in patients with reduced ejection fraction after myocardial infarction without atrial fibrillation. J Am Coll Cardiol. 2018;71:727–35. [DOI] [PubMed] [Google Scholar]
- [16].Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115–26. [DOI] [PubMed] [Google Scholar]
- [17].Kannel WB, Wolf PA. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study. Curr Atheroscler Rep. 2006;8:317–23. [DOI] [PubMed] [Google Scholar]
- [18].Roth EJ, Mueller K, Green D. Stroke rehabilitation outcome: impact of coronary artery disease. Stroke. 1988;19:42–7. [DOI] [PubMed] [Google Scholar]
- [19].Desrosiers J, Malouin F, Richards C, et al. Comparison of changes in upper and lower extremity impairments and disabilities after stroke. Int J Rehabil Res. 2003;26:109–16. [DOI] [PubMed] [Google Scholar]
- [20].Nagai T, Okita K, Yonezawa K, et al. Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure. Circ J. 2004;68:573–9. [DOI] [PubMed] [Google Scholar]
- [21].Harris-Love MO, Benson K, Leasure E, et al. The influence of upper and lower extremity strength on performance-based sarcopenia assessment tests. J Funct Morphol Kinesiol. 2018;3:53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Kemmler W, von Stengel S, Schoene D. Longitudinal changes in muscle mass and function in older men at increased risk for sarcopenia - The FrOST-study. J Frailty Aging. 2019;8:57–61. [DOI] [PubMed] [Google Scholar]

